Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-… (NCT01247779) | Clinical Trial Compass
CompletedNot Applicable
Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy
France386 participantsStarted 2010-12
Plain-language summary
The purpose of this study is to compare perioperative morbidity of coelioscopy versus robot-assisted coelioscopy in cervical cancer, uterus cancer and ovarian cancer.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* patient with uterus cancer depending on hysterectomy ± pelvic lymphadenectomy or a restadification
* patient with cervical cancer depending on enlarged colpo-hysterectomy ± pelvic lymphadenectomy or a surgery after concomitant radiochemotherapy, or lombo aortic lymphadenectomy for a locally advanced cancer, or a restadification
* patient with cervical cancer depending on a restadification
* patient aged over 18 years
* previous antitumor treatment allowed but necessarily disrupted 20 days before inclusion
* WHO score equal or inferior to 3
* cirrhosis-related Child-Pugh score under or equal to A7 are allowed
* life expectancy equal or superior to 12 weeks
* patient affiliated to health insurance
* dated and signed informed consent
Exclusion Criteria:
* metastatic disease
* pregnant or breastfeeding woman
* patient unable to proceed follow-up visit, because of geographic, social or mental reasons